vs
STANDARD BIOTOOLS INC.（LAB）与花花公子（PLBY）财务数据对比。点击上方公司名可切换其他公司
花花公子的季度营收约是STANDARD BIOTOOLS INC.的1.8倍（$34.9M vs $19.6M），花花公子净利率更高（10.3% vs -177.4%，领先187.7%），花花公子同比增速更快（4.2% vs -11.5%），花花公子自由现金流更多（$1.1M vs $-23.1M），过去两年花花公子的营收复合增速更高（11.0% vs -12.2%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
花花公子集团（Playboy, Inc.）起源于1953年由休·海夫纳联合合伙人在美国芝加哥创立，初始部分资金来自海夫纳母亲提供的1000美元贷款，是美国知名生活方式与娱乐内容品牌，旗下核心《花花公子》杂志同时发行电子版与纸质版。
LAB vs PLBY — 直观对比
营收规模更大
PLBY
是对方的1.8倍
$19.6M
营收增速更快
PLBY
高出15.7%
-11.5%
净利率更高
PLBY
高出187.7%
-177.4%
自由现金流更多
PLBY
多$24.2M
$-23.1M
两年增速更快
PLBY
近两年复合增速
-12.2%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $34.9M |
| 净利润 | $-34.7M | $3.6M |
| 毛利率 | 48.5% | 73.3% |
| 营业利润率 | -168.5% | 7.9% |
| 净利率 | -177.4% | 10.3% |
| 营收同比 | -11.5% | 4.2% |
| 净利润同比 | -28.8% | 128.6% |
| 每股收益（稀释后） | $-0.09 | $0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LABPLBY
| Q4 25 | — | $34.9M | ||
| Q3 25 | $19.6M | $29.0M | ||
| Q2 25 | $21.8M | $28.1M | ||
| Q1 25 | $40.8M | $28.9M | ||
| Q4 24 | — | $33.5M | ||
| Q3 24 | $22.1M | $29.4M | ||
| Q2 24 | $22.5M | $24.9M | ||
| Q1 24 | $45.5M | $28.3M |
净利润LABPLBY
| Q4 25 | — | $3.6M | ||
| Q3 25 | $-34.7M | $460.0K | ||
| Q2 25 | $-33.5M | $-7.7M | ||
| Q1 25 | $-26.0M | $-9.0M | ||
| Q4 24 | — | $-12.5M | ||
| Q3 24 | $-26.9M | $-33.8M | ||
| Q2 24 | $-45.7M | $-16.7M | ||
| Q1 24 | $-32.2M | $-16.4M |
毛利率LABPLBY
| Q4 25 | — | 73.3% | ||
| Q3 25 | 48.5% | 76.0% | ||
| Q2 25 | 48.8% | 65.4% | ||
| Q1 25 | 48.4% | 68.6% | ||
| Q4 24 | — | 70.8% | ||
| Q3 24 | 54.9% | 61.0% | ||
| Q2 24 | 46.1% | 67.8% | ||
| Q1 24 | 53.1% | 55.8% |
营业利润率LABPLBY
| Q4 25 | — | 7.9% | ||
| Q3 25 | -168.5% | 4.7% | ||
| Q2 25 | -118.1% | -20.9% | ||
| Q1 25 | -80.8% | -21.7% | ||
| Q4 24 | — | -13.3% | ||
| Q3 24 | -120.9% | -96.0% | ||
| Q2 24 | -134.5% | -37.0% | ||
| Q1 24 | -132.2% | -31.5% |
净利率LABPLBY
| Q4 25 | — | 10.3% | ||
| Q3 25 | -177.4% | 1.6% | ||
| Q2 25 | -153.7% | -27.3% | ||
| Q1 25 | -63.8% | -31.3% | ||
| Q4 24 | — | -37.4% | ||
| Q3 24 | -122.0% | -114.7% | ||
| Q2 24 | -203.3% | -66.9% | ||
| Q1 24 | -70.6% | -58.1% |
每股收益（稀释后）LABPLBY
| Q4 25 | — | $0.05 | ||
| Q3 25 | $-0.09 | $0.00 | ||
| Q2 25 | $-0.09 | $-0.08 | ||
| Q1 25 | $-0.07 | $-0.10 | ||
| Q4 24 | — | $-0.13 | ||
| Q3 24 | $-0.07 | $-0.45 | ||
| Q2 24 | $-0.12 | $-0.23 | ||
| Q1 24 | $-0.27 | $-0.23 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $37.8M |
| 总债务越低越好 | — | $174.2M |
| 股东权益账面价值 | $399.7M | $18.4M |
| 总资产 | $539.6M | $292.4M |
| 负债/权益比越低杠杆越低 | — | 9.48× |
8季度趋势，按日历期对齐
现金及短期投资LABPLBY
| Q4 25 | — | $37.8M | ||
| Q3 25 | $129.4M | $27.5M | ||
| Q2 25 | $158.6M | $19.6M | ||
| Q1 25 | $150.9M | $23.7M | ||
| Q4 24 | — | $30.9M | ||
| Q3 24 | $210.6M | $9.5M | ||
| Q2 24 | $269.8M | $16.9M | ||
| Q1 24 | $287.1M | $19.0M |
总债务LABPLBY
| Q4 25 | — | $174.2M | ||
| Q3 25 | — | $176.8M | ||
| Q2 25 | — | $177.5M | ||
| Q1 25 | — | $176.3M | ||
| Q4 24 | — | $176.6M | ||
| Q3 24 | $55.2M | $200.0M | ||
| Q2 24 | $55.1M | $196.3M | ||
| Q1 24 | $55.0M | $193.4M |
股东权益LABPLBY
| Q4 25 | — | $18.4M | ||
| Q3 25 | $399.7M | $3.8M | ||
| Q2 25 | $424.5M | $-17.5M | ||
| Q1 25 | $454.6M | $-11.4M | ||
| Q4 24 | — | $-7.7M | ||
| Q3 24 | $489.3M | $-15.7M | ||
| Q2 24 | $510.3M | $15.7M | ||
| Q1 24 | $577.3M | $29.5M |
总资产LABPLBY
| Q4 25 | — | $292.4M | ||
| Q3 25 | $539.6M | $278.3M | ||
| Q2 25 | $557.0M | $264.1M | ||
| Q1 25 | $579.6M | $270.6M | ||
| Q4 24 | — | $284.7M | ||
| Q3 24 | $681.5M | $271.5M | ||
| Q2 24 | $708.7M | $301.8M | ||
| Q1 24 | $777.7M | $309.1M |
负债/权益比LABPLBY
| Q4 25 | — | 9.48× | ||
| Q3 25 | — | 46.86× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 0.11× | 12.51× | ||
| Q1 24 | 0.10× | 6.54× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $1.4M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $1.1M |
| 自由现金流率自由现金流/营收 | -118.1% | 3.2% |
| 资本支出强度资本支出/营收 | 4.5% | 0.8% |
| 现金转化率经营现金流/净利润 | — | 0.39× |
| 过去12个月自由现金流最近4个季度 | $-111.1M | $-1.0M |
8季度趋势，按日历期对齐
经营现金流LABPLBY
| Q4 25 | — | $1.4M | ||
| Q3 25 | $-22.2M | $10.1M | ||
| Q2 25 | $-20.7M | $-3.9M | ||
| Q1 25 | $-30.3M | $-7.6M | ||
| Q4 24 | — | $161.0K | ||
| Q3 24 | $-27.9M | $-6.5M | ||
| Q2 24 | $-39.0M | $-3.0M | ||
| Q1 24 | $-62.5M | $-9.8M |
自由现金流LABPLBY
| Q4 25 | — | $1.1M | ||
| Q3 25 | $-23.1M | $9.8M | ||
| Q2 25 | $-22.6M | $-4.3M | ||
| Q1 25 | $-35.3M | $-7.7M | ||
| Q4 24 | — | $-401.0K | ||
| Q3 24 | $-30.1M | $-7.0M | ||
| Q2 24 | $-41.0M | $-3.7M | ||
| Q1 24 | $-63.3M | $-10.3M |
自由现金流率LABPLBY
| Q4 25 | — | 3.2% | ||
| Q3 25 | -118.1% | 33.8% | ||
| Q2 25 | -103.6% | -15.2% | ||
| Q1 25 | -86.6% | -26.5% | ||
| Q4 24 | — | -1.2% | ||
| Q3 24 | -136.4% | -23.7% | ||
| Q2 24 | -182.2% | -14.8% | ||
| Q1 24 | -138.9% | -36.5% |
资本支出强度LABPLBY
| Q4 25 | — | 0.8% | ||
| Q3 25 | 4.5% | 1.1% | ||
| Q2 25 | 8.7% | 1.4% | ||
| Q1 25 | 12.4% | 0.1% | ||
| Q4 24 | — | 1.7% | ||
| Q3 24 | 10.2% | 1.5% | ||
| Q2 24 | 8.6% | 2.6% | ||
| Q1 24 | 1.7% | 2.1% |
现金转化率LABPLBY
| Q4 25 | — | 0.39× | ||
| Q3 25 | — | 22.02× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
PLBY
| Transferred At Point In Time | $22.2M | 64% |
| Trademark Licensing | $6.5M | 19% |
| Related Party | $5.0M | 14% |
| Other | $1.1M | 3% |
